Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018

This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.

Detalles Bibliográficos
Autores principales: Alpern, Jonathan D., Joo, Heesoo, Link, Ben, Ciaccia, Antonio, Stauffer, William M., Bahr, Nathan C., Leventhal, Thomas M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783269/
https://www.ncbi.nlm.nih.gov/pubmed/35061044
http://dx.doi.org/10.1001/jamanetworkopen.2021.44521
Descripción
Sumario:This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.

Ejemplares similares